Swiss National Bank lowered its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 2.8% during the second quarter, HoldingsChannel.com reports. The firm owned 893,822 shares of the company’s stock after selling 25,300 shares during the period. Swiss National Bank’s holdings in HCA Healthcare were worth $120,818,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the business. Magellan Asset Management Ltd raised its stake in HCA Healthcare by 2.0% during the first quarter. Magellan Asset Management Ltd now owns 12,908,938 shares of the company’s stock worth $1,683,067,000 after purchasing an additional 258,477 shares during the period. AQR Capital Management LLC raised its stake in HCA Healthcare by 11.1% during the first quarter. AQR Capital Management LLC now owns 3,555,318 shares of the company’s stock worth $461,160,000 after purchasing an additional 355,406 shares during the period. Geode Capital Management LLC increased its position in shares of HCA Healthcare by 10.0% in the fourth quarter. Geode Capital Management LLC now owns 3,414,676 shares of the company’s stock worth $424,189,000 after acquiring an additional 310,086 shares in the last quarter. Janus Henderson Group PLC increased its position in shares of HCA Healthcare by 33.6% in the first quarter. Janus Henderson Group PLC now owns 2,368,547 shares of the company’s stock worth $308,812,000 after acquiring an additional 596,056 shares in the last quarter. Finally, Parametric Portfolio Associates LLC increased its position in shares of HCA Healthcare by 3.9% in the first quarter. Parametric Portfolio Associates LLC now owns 1,499,343 shares of the company’s stock worth $195,484,000 after acquiring an additional 55,925 shares in the last quarter. 70.23% of the stock is currently owned by institutional investors.
Several equities research analysts have recently issued reports on the stock. Stephens set a $150.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Raymond James raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $115.00 to $135.00 in a research report on Tuesday, April 23rd. Deutsche Bank increased their price objective on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Finally, Goldman Sachs Group raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $147.00 to $160.00 in a research report on Wednesday, July 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and seventeen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $153.35.
HCA traded up $0.66 during trading hours on Friday, reaching $123.93. 1,444,200 shares of the stock traded hands, compared to its average volume of 1,970,735. The firm’s fifty day simple moving average is $135.04 and its two-hundred day simple moving average is $131.44. The company has a market cap of $42.03 billion, a price-to-earnings ratio of 12.68, a PEG ratio of 1.06 and a beta of 0.85. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.49 by ($0.28). The firm had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. HCA Healthcare’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.29 earnings per share. Analysts predict that HCA Healthcare Inc will post 10.35 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s payout ratio is 16.38%.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: How Investors Can Profit from Options Trading
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.